Zhdanava M, Pilon D, Ghelerter I, Chow W, Joshi K, Lefebvre P, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiatry. 2021;82:e1–7.

Article  Google Scholar 

Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry. 2004;16:260–83.

Article  PubMed  Google Scholar 

Wray NR, Gottesman II. Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet. 2012;3:118.

Article  PubMed  PubMed Central  Google Scholar 

Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry. 2000;157:1552–62.

Article  PubMed  CAS  Google Scholar 

Pettersson E, Lichtenstein P, Larsson H, Song J, Agrawal A, Børglum AD, et al. Genetic influences on eight psychiatric disorders based on family data of 4 408 646 full and half-siblings, and genetic data of 333 748 cases and controls. Psychological Med. 2019;49:1166–73.

Article  CAS  Google Scholar 

Levinson DF, Mostafavi S, Milaneschi Y, Rivera M, Ripke S, Wray NR, et al. Genetic studies of major depressive disorder: Why are there no genome-wide association study findings and what can we do about it? Biol Psychiatry. 2014;76:510–2.

Article  PubMed  PubMed Central  Google Scholar 

Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 2016;48:1031–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wray NR, Trzaskowski M, Byrne EM, Abdellaoui A, Adams MJ, Agerbo E, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Howard DM, Adams MJ, Clarke T, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22:343–52.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract. 2007;57:144–51.

PubMed  PubMed Central  Google Scholar 

Flint J. The genetic basis of major depressive disorder. Mol Psychiatry. 2023;28:2254–65.

Article  PubMed  PubMed Central  Google Scholar 

Zeggini E, Panoutsopoulou K, Southam L, Rayner NW, Day-Williams AG, Lopes MC, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): A genome-wide association study. Lancet. 2012;380:815–23.

Article  PubMed  Google Scholar 

Wain LV, Shrine N, Artigas MS, Erzurumluoglu AM, Noyvert B, Bossini-Castillo L, et al. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nature Genet. 2017;49:416–25.

Article  PubMed  CAS  Google Scholar 

Soda T, McLoughlin DM, Clark SR, Oltedal L, Kessler U, Haavik J, et al. International consortium on the genetics of electroconvulsive therapy and severe depressive disorders (gen-ECT-ic). Eur Arch Psychiatry Clin Neurosci. 2020;270:921–32.

Article  PubMed  Google Scholar 

Mathew SJ, Wilkinson ST, Altinay M, Asghar-Ali A, Chang LC, Collins KA, et al. Electroconvulsive therapy (ECT) vs. ketamine in patients with treatment-resistant depression: The ELEKT-D study protocol. Contemp Clin Trials. 2019;77:19–26.

Article  PubMed  Google Scholar 

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association Publishing; 2022.

World Health Organization. International statistical classification of diseases and related health problems. Geneva: World Health Organization; 2019.

Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150:384–8.

Article  PubMed  Google Scholar 

Zimmerman M, Balling C, Chelminski I, Dalrymple K. Understanding the severity of depression: Which symptoms of depression are the best indicators of depression severity? Compr Psychiatry. 2018;87:84–8.

Article  PubMed  Google Scholar 

Roose SP, Glassman AH, Walsh BT, Woodring S, Vital-herne J. Depression, delusions, and suicide. Am J Psychiatry. 1983;140:1159–62.

Article  PubMed  CAS  Google Scholar 

Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry. 1994;151:489–98.

Article  PubMed  CAS  Google Scholar 

Zisook S, Lesser I, Stewart JW, Wisniewski SR, Balasubramani GK, Fava M, et al. Effect of age at onset on the course of major depressive disorder. Am J Psychiatry. 2007;164:1539–46.

Article  PubMed  Google Scholar 

Zimmerman M, Morgan TA, Stanton K. The severity of psychiatric disorders. World Psychiatry. 2018;17:258–75.

Article  PubMed  PubMed Central  Google Scholar 

Miller CH, Sacchet MD, Gotlib IH. Support vector machines and affective science. Emotion Rev. 2020;12:297–308.

Article  Google Scholar 

Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry. 2003;53:649–59.

Article  PubMed  Google Scholar 

McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, et al. Treatment‐resistant depression: Definition, prevalence, detection, management, and investigational interventions. World Psychiatry. 2023;22:394–412.

Article  PubMed  PubMed Central  Google Scholar 

National Institute for Health and Care Excellence. Depression in adults: Treatment and management, NICE guideline NG222. London, UK: NICE; 2022. Accessed 9 June 2024.

Food and Drug Administration. Neurological devices; reclassification of electroconvulsive therapy devices; effective date of requirement for premarket approval for electroconvulsive therapy devices for certain specified intended uses. final order. Federal register. 2018;83:66103–24.

Google Scholar 

Kaster TS, Blumberger DM, Gomes T, Sutradhar R, Dasklakis ZJ, Wijeysundera DN, et al. Patient-level characteristics and inequitable access to inpatient electroconvulsive therapy for depression: A population-based cross-sectional study: Caractéristiques au niveau du patient et accès inéquitable à la thérapie électroconvulsive pour patients hospitalisés. Can J Psychiatry. 2021;66:147–58.

Article  PubMed  Google Scholar 

Jørgensen MB, Rozing MP, Kellner CH, Osler M. Electroconvulsive therapy, depression severity and mortality: Data from the Danish national patient registry. J Psychopharmacol. 2020;34:273–9.

Article  PubMed  Google Scholar 

Kellner C, Kaicher D, Banerjee H, Knapp R, Shapiro R, Briggs M, et al. Depression severity in electroconvulsive therapy (ECT) versus pharmacotherapy trials. J ECT. 2015;31:31–3.

Article  PubMed  Google Scholar 

Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. The clinical characteristics of major depression as indices of the familial risk to illness. Br J Psychiatry. 1994;165:66–72.

Article  PubMed  CAS  Google Scholar 

Torgersen S. Genetic factors in moderately severe and mild affective disorders. Arch Gen Psychiatry. 1986;43:222–6.

Article  PubMed  CAS  Google Scholar 

Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry. 1982;39:1157–67.

Article  PubMed  CAS  Google Scholar 

Weissman MM, Kidd KK, Prusoff BA. Variability in rates of affective disorders in relatives of depressed and normal probands. Arch Gen Psychiatry. 1982;39:1397–403.

Article  PubMed  CAS  Google Scholar 

Cadoret RJ, Woolson R, Winokur G. The relationship of age of onset in unipolar affective disorder to risk of alcoholism and depression in parents. J Psychiatr Res. 1977;13:137–42.